PRAMEF12, a novel cancer/testis gene, regulates proliferation and apoptosis to promote progression of glioma

References

• Stupp R, Mason WP, van den Bent MJ et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 352(10), 987–996 (2005).
   PubMed Web of Science ®Google Scholar
• Mitchell DA, Fecci PE, Sampson JH. Immunotherapy of malignant brain tumors. Immunol. Rev. 222, 70–100 (2008).
   PubMed Web of Science ®Google Scholar
• Grauer OM, Wesseling P, Adema GJ. Immunotherapy of diffuse gliomas: biological background, current status and future developments. Brain Pathol. 19(4), 674–693 (2009).
   PubMed Web of Science ®Google Scholar
• Scanlan MJ, Simpson AJ, Old LJ. The cancer/testis genes: review, standardization, and commentary. Cancer Immun. 4, 1 (2004).
   PubMedGoogle Scholar
• Suri A. Cancer testis antigens – their importance in immunotherapy and in the early detection of cancer. Expert Opin. Biol. Ther. 6(4), 379–389 (2006).
   PubMed Web of Science ®Google Scholar
• CTDatabase. http://www.cta.lncc.br/
   Google Scholar
• Fratta E, Coral S, Covre A et al. The biology of cancer testis antigens: putative function, regulation and therapeutic potential. Mol. Oncol. 5(2), 164–182 (2011).
   PubMed Web of Science ®Google Scholar
• Phuphanich S, Wheeler CJ, Rudnick JD et al. Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma. Cancer Immunol. Immunother. 62(1), 125–135 (2013).
   PubMed Web of Science ®Google Scholar
• Field MG, Decatur CL, Kurtenbach S et al. PRAME as an independent biomarker for metastasis in uveal melanoma. Clin. Cancer Res. 22(5), 1234–1242 (2016).
   PubMed Web of Science ®Google Scholar
• Li J, Yin J, Zhong J, Yang Z, Tang A, Li S. Clinicopathological and prognostic significance of PRAME overexpression in human cancer: a meta-analysis. Biomed. Res. Int. 2020, 8828579 (2020).
   PubMed Web of Science ®Google Scholar
• Hermes N, Kewitz S, Staege MS. Preferentially expressed antigen in melanoma (PRAME) and the PRAME family of leucine-rich repeat proteins. Curr. Cancer Drug Targets 16(5), 400–414 (2016).
   PubMed Web of Science ®Google Scholar
• Hofmann O, Caballero OL, Stevenson BJ et al. Genome-wide analysis of cancer/testis gene expression. Proc. Natl Acad. Sci. USA 105(51), 20422–20427 (2008).
   PubMed Web of Science ®Google Scholar
• Grigoriadis A, Caballero OL, Hoek KS et al. CT-X antigen expression in human breast cancer. Proc. Natl Acad. Sci. USA 106(32), 13493–13498 (2009).
   PubMed Web of Science ®Google Scholar
• Li J, Zou X, Li C et al. Expression of novel cancer/testis antigen TMEM31 increases during metastatic melanoma progression. Oncol. Lett. 13(4), 2269–2273 (2017).
   PubMed Web of Science ®Google Scholar
• Lapointe S, Perry A, Butowski NA. Primary brain tumours in adults. Lancet 392(10145), 432–446 (2018).
   PubMed Web of Science ®Google Scholar
• Laug D, Glasgow SM, Deneen B. A glial blueprint for gliomagenesis. Nature Rev. Neurosci. 19(7), 393–403 (2018).
   PubMed Web of Science ®Google Scholar
• Ponten F, Jirstrom K, Uhlen M. The Human Protein Atlas–a tool for pathology. J. Pathol. 216(4), 387–393 (2008).
   PubMed Web of Science ®Google Scholar
• Mizuno H, Kitada K, Nakai K, Sarai A. PrognoScan: a new database for meta-analysis of the prognostic value of genes. BMC Med. Genomics 2, 18 (2009).
   PubMed Web of Science ®Google Scholar
• Vasaikar SV, Straub P, Wang J, Zhang B. LinkedOmics: analyzing multi-omics data within and across 32 cancer types. Nucleic Acids Res. 46(D1), D956–D963 (2018).
   PubMed Web of Science ®Google Scholar
• Warde-Farley D, Donaldson SL, Comes O et al. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res. 38, W214–220 (2010).
   PubMed Web of Science ®Google Scholar
• Szklarczyk D, Gable AL, Lyon D et al. STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 47(D1), D607–D613 (2019).
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zhou B, Pache L et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun. 10(1), 1523 (2019).
   PubMed Web of Science ®Google Scholar
• Marumoto T, Saya H. Molecular biology of glioma. Adv. Exp. Med. Biol. 746, 2–11 (2012).
   PubMed Web of Science ®Google Scholar
• Wang Y, Jiang T. Understanding high grade glioma: molecular mechanism, therapy and comprehensive management. Cancer Lett. 331(2), 139–146 (2013).
   PubMed Web of Science ®Google Scholar
• Song MH, Choi KU, Shin DH, Lee CH, Lee SY. Identification of the cancer/testis antigens AKAP3 and CTp11 by SEREX in hepatocellular carcinoma. Oncol. Rep. 28(5), 1792–1798 (2012).
   PubMed Web of Science ®Google Scholar
• Caballero OL, Chen YT. Cancer/testis (CT) antigens: potential targets for immunotherapy. Cancer Sci. 100(11), 2014–2021 (2009).
   PubMed Web of Science ®Google Scholar
• Zhang XY, Yan QX, Guo XY et al. Expression profile of SPACA5/Spaca5 in spermatogenesis and transitional cell carcinoma of the bladder. Oncol. Lett. 12(5), 3731–3738 (2016).
   PubMed Web of Science ®Google Scholar
• Wang Z, Xu X, Li JL, Palmer C, Maric D, Dean J. Sertoli cell-only phenotype and scRNA-seq define PRAMEF12 as a factor essential for spermatogenesis in mice. Nat. Commun. 10(1), 5196 (2019).
   PubMedGoogle Scholar
• Syed ON, Mandigo CE, Killory BD, Canoll P, Bruce JN. Cancer-testis and melanocyte-differentiation antigen expression in malignant glioma and meningioma. J. Clin. Neurosci. 19(7), 1016–1021 (2012).
   PubMed Web of Science ®Google Scholar
• Freitas M, Malheiros S, Stavale JN et al. Expression of cancer/testis antigens is correlated with improved survival in glioblastoma. Oncotarget 4(4), 636–646 (2013).
   PubMed Web of Science ®Google Scholar
• Nylund C, Rappu P, Pakula E et al. Melanoma-associated cancer-testis antigen 16 (CT16) regulates the expression of apoptotic and antiapoptotic genes and promotes cell survival. PLOS ONE 7(9), e45382 (2012).
   PubMed Web of Science ®Google Scholar
• Kanojia D, Garg M, Saini S et al. Sperm associated antigen 9 plays an important role in bladder transitional cell carcinoma. PLOS ONE 8(12), e81348 (2013).
   PubMed Web of Science ®Google Scholar
• Hu Y, Xing J, Wang L et al. RGS22, a novel cancer/testis antigen, inhibits epithelial cell invasion and metastasis. Clin. Exp. Metastasis 28(6), 541–549 (2011).
   PubMed Web of Science ®Google Scholar
• Christodoulou CC, Zachariou M, Tomazou M et al. Investigating the transition of pre-symptomatic to symptomatic Huntington’s disease status based on omics data. Int. J. Mol. Sci. 21(19), 7414 (2020).
   PubMed Web of Science ®Google Scholar
• Bugter JM, Fenderico N, Maurice MM. Mutations and mechanisms of WNT pathway tumour suppressors in cancer. Nat. Rev. Cancer 21(1), 5–21 (2021).
   PubMed Web of Science ®Google Scholar
• Zhan T, Rindtorff N, Boutros M. Wnt signaling in cancer. Oncogene 36(11), 1461–1473 (2017).
   PubMed Web of Science ®Google Scholar